Goldman Sachs Maintains Owens & Minor Rating And Price Target

Loading...
Loading...
Owens & Minor, Inc.
OMI
reported FY3Q10 EPS of $0.50, versus our/consensus estimates at $0.48/$0.49, Goldman Sachs reports. Revenue grew 1.4% year-over-year in the face of challenging utilization trends, which was relatively in line with Street expectations and 2.5% above Goldman Sachs' expectations. “While the quarter was slightly better than what we perceived to be low expectations, we still believe hospital utilization trends pose a significant headwind and are likely to persist beyond this year,” Goldman Sachs writes. “We maintain our Sell rating and $25 12-month price target.” Owens & Minor closed Monday at $27.94.
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst RatingsGoldman SachsHealth CareHealth Care DistributorsOwens & Minor
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...